Alpha-Synuclein SAA Predicts Parkinson’s Levodopa Response Durability
A 2026 PPMI analysis found that Parkinson’s patients with positive CSF α-synuclein seed amplification assay results kept gaining levodopa benefit over follow-up, while SAA-negative patients …
Read article